95 related articles for article (PubMed ID: 18043718)
61. A pan-European study of the C9orf72 repeat associated with FTLD: geographic prevalence, genomic instability, and intermediate repeats.
van der Zee J; Gijselinck I; Dillen L; Van Langenhove T; Theuns J; Engelborghs S; Philtjens S; Vandenbulcke M; Sleegers K; Sieben A; Bäumer V; Maes G; Corsmit E; Borroni B; Padovani A; Archetti S; Perneczky R; Diehl-Schmid J; de Mendonça A; Miltenberger-Miltenyi G; Pereira S; Pimentel J; Nacmias B; Bagnoli S; Sorbi S; Graff C; Chiang HH; Westerlund M; Sanchez-Valle R; Llado A; Gelpi E; Santana I; Almeida MR; Santiago B; Frisoni G; Zanetti O; Bonvicini C; Synofzik M; Maetzler W; Vom Hagen JM; Schöls L; Heneka MT; Jessen F; Matej R; Parobkova E; Kovacs GG; Ströbel T; Sarafov S; Tournev I; Jordanova A; Danek A; Arzberger T; Fabrizi GM; Testi S; Salmon E; Santens P; Martin JJ; Cras P; Vandenberghe R; De Deyn PP; Cruts M; Van Broeckhoven C; van der Zee J; Gijselinck I; Dillen L; Van Langenhove T; Theuns J; Philtjens S; Sleegers K; Bäumer V; Maes G; Corsmit E; Cruts M; Van Broeckhoven C; van der Zee J; Gijselinck I; Dillen L; Van Langenhove T; Philtjens S; Theuns J; Sleegers K; Bäumer V; Maes G; Cruts M; Van Broeckhoven C; Engelborghs S; De Deyn PP; Cras P; Engelborghs S; De Deyn PP; Vandenbulcke M; Vandenbulcke M; Borroni B; Padovani A; Archetti S; Perneczky R; Diehl-Schmid J; Synofzik M; Maetzler W; Müller Vom Hagen J; Schöls L; Synofzik M; Maetzler W; Müller Vom Hagen J; Schöls L; Heneka MT; Jessen F; Ramirez A; Kurzwelly D; Sachtleben C; Mairer W; de Mendonça A; Miltenberger-Miltenyi G; Pereira S; Firmo C; Pimentel J; Sanchez-Valle R; Llado A; Antonell A; Molinuevo J; Gelpi E; Graff C; Chiang HH; Westerlund M; Graff C; Kinhult Ståhlbom A; Thonberg H; Nennesmo I; Börjesson-Hanson A; Nacmias B; Bagnoli S; Sorbi S; Bessi V; Piaceri I; Santana I; Santiago B; Santana I; Helena Ribeiro M; Rosário Almeida M; Oliveira C; Massano J; Garret C; Pires P; Frisoni G; Zanetti O; Bonvicini C; Sarafov S; Tournev I; Jordanova A; Tournev I; Kovacs GG; Ströbel T; Heneka MT; Jessen F; Ramirez A; Kurzwelly D; Sachtleben C; Mairer W; Jessen F; Matej R; Parobkova E; Danel A; Arzberger T; Maria Fabrizi G; Testi S; Ferrari S; Cavallaro T; Salmon E; Santens P; Cras P;
Hum Mutat; 2013 Feb; 34(2):363-73. PubMed ID: 23111906
[TBL] [Abstract][Full Text] [Related]
62. TMEM106B a novel risk factor for frontotemporal lobar degeneration.
van der Zee J; Van Broeckhoven C
J Mol Neurosci; 2011 Nov; 45(3):516-21. PubMed ID: 21614538
[TBL] [Abstract][Full Text] [Related]
63. Screening for replication of genome-wide SNP associations in sporadic ALS.
Cronin S; Tomik B; Bradley DG; Slowik A; Hardiman O
Eur J Hum Genet; 2009 Feb; 17(2):213-8. PubMed ID: 18987618
[TBL] [Abstract][Full Text] [Related]
64. Redox modifier genes in amyotrophic lateral sclerosis in mice.
Marden JJ; Harraz MM; Williams AJ; Nelson K; Luo M; Paulson H; Engelhardt JF
J Clin Invest; 2007 Oct; 117(10):2913-9. PubMed ID: 17853944
[TBL] [Abstract][Full Text] [Related]
65. SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model.
Harraz MM; Marden JJ; Zhou W; Zhang Y; Williams A; Sharov VS; Nelson K; Luo M; Paulson H; Schöneich C; Engelhardt JF
J Clin Invest; 2008 Feb; 118(2):659-70. PubMed ID: 18219391
[TBL] [Abstract][Full Text] [Related]
66. Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA.
Wang J; Xu G; Slunt HH; Gonzales V; Coonfield M; Fromholt D; Copeland NG; Jenkins NA; Borchelt DR
Neurobiol Dis; 2005 Dec; 20(3):943-52. PubMed ID: 16046140
[TBL] [Abstract][Full Text] [Related]
67. Swelling and vacuolisation of mitochondria in transgenic SOD1-ALS mice: a consequence of supranormal SOD1 expression?
Jaarsma D
Mitochondrion; 2006 Feb; 6(1):48-9; author reply 50-1. PubMed ID: 16410057
[No Abstract] [Full Text] [Related]
68. MRI detects early hindlimb muscle atrophy in Gly93Ala superoxide dismutase-1 (G93A SOD1) transgenic mice, an animal model of familial amyotrophic lateral sclerosis.
Brooks KJ; Hill MD; Hockings PD; Reid DG
NMR Biomed; 2004 Feb; 17(1):28-32. PubMed ID: 15011248
[TBL] [Abstract][Full Text] [Related]
69. ALS predisposition modifiers: knock NOX, who's there? SOD1 mice still are.
Valdmanis PN; Kabashi E; Dion PA; Rouleau GA
Eur J Hum Genet; 2008 Feb; 16(2):140-2. PubMed ID: 18043718
[No Abstract] [Full Text] [Related]
70. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS.
Turner BJ; Talbot K
Prog Neurobiol; 2008 May; 85(1):94-134. PubMed ID: 18282652
[TBL] [Abstract][Full Text] [Related]
71. [ALS models by transgenic animals].
Aoki M; Nagai M; Kato M; Itoyama Y
No To Shinkei; 2001 Sep; 53(9):799-807. PubMed ID: 11596474
[No Abstract] [Full Text] [Related]
72. Genetics of amyotrophic lateral sclerosis.
Robberecht W
J Neurol; 2000 Dec; 247 Suppl 6():VI/2-6. PubMed ID: 19714405
[TBL] [Abstract][Full Text] [Related]
73. Amyotrophic lateral sclerosis as a complex genetic disease.
Simpson CL; Al-Chalabi A
Biochim Biophys Acta; 2006; 1762(11-12):973-85. PubMed ID: 16973338
[TBL] [Abstract][Full Text] [Related]
74.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
75.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
76.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
77.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
78.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
